Regeneron and Sanofi declare plans to make Praluent more accessible for patients at high risk Read more
Janssen Pharmaceutical’s INVOKANA alleviates risk of CV death or HHF in type 2 diabetes patients Read more
Soin Neuroscience secures IRB approval to commence clinical case series studying spinal cord stimulator alogrithms Read more